India: Legatum invests $8.4-million in Intellecap

Print
 
Oct 2007
Mumbai, India, October, 08 2007 - Legatum, a private firm that invests in global capital markets and in initiatives that support social development, on Monday said it has invested Rs 34 crore ($8.4-million) in Intellecap.

Intellecap provides business advisory services for investors and companies that seek both a financial and sustainable social return on investment.

"Intellecap is an innovative and entrepreneurial company that has created a unique niche, intermediating financial capital into development-oriented businesses operating in India's poorest communities," Legatum's Senior Vice-President Philip Vassilou said in a statement issued here.

"Intellecap will now seek to extend and develop its combination of world-class services and people, delivering independent, impartial and insightful enterprise solutions," he added.

Intellecap's Co-Founder Vineet Rai said "our business has been built upon a passion for sustainable development and an objective approach to the mainstream solutions that support it."

Legatum's investment would ensure that Intellecap is positioned to build new initiatives in the field of finance and strategy in the micro-finance sector as well as other areas that benefit social and economic development.

"Sectors of focus for Intellecap will include health, education and technology. Intellecap also plans to expand its services in India and beyond, thereby providing investors with necessary support and expertise to identify and realise a wide range of opportunities," the statement added.

 

Research Analysis Tools

The fund indexes, institution benchmarks and other market information displayed here are all Symbiotics designed analysis tools, created in-house by our analysts and experts. Symbiotics has one of the oldest track records in microfinance investment analysis dating back to the late 1990s; its indexes and benchmarks have been regularly used as markers by investors, asset managers, financial institutions and practitioners. These, as well as several other research products, are available through the Research Account. Click on the link below to find out more.

Learn More